Systematic Reviews of Diagnostic Test Accuracy
暂无分享,去创建一个
Patrick Bossuyt | Constantine Gatsonis | Mariska Leeflang | C. Gatsonis | P. Bossuyt | M. Leeflang | P. Bossuyt | J. Deeks | Jonathan Deeks
[1] M. Weinstein,et al. Decision Making in Health and Medicine , 2001 .
[2] Lucas M Bachmann,et al. Communicating accuracy of tests to general practitioners: a controlled study , 2002, BMJ : British Medical Journal.
[3] M. Correale,et al. Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer. , 1998, Anticancer Research.
[4] P. Bossuyt. Interpreting diagnostic test accuracy studies. , 2008, Seminars in hematology.
[5] Lucas M. Bachmann,et al. Research Paper: Identifying Diagnostic Studies in MEDLINE: Reducing the Number Needed to Read , 2002, J. Am. Medical Informatics Assoc..
[6] Xiao-Hua Zhou,et al. Statistical Methods in Diagnostic Medicine , 2002 .
[7] Milo Puhan,et al. A Randomized Trial of Ways To Describe Test Accuracy: The Effect on Physicians' Post-Test Probability Estimates , 2005, Annals of Internal Medicine.
[8] Johannes B Reitsma,et al. Evidence of bias and variation in diagnostic accuracy studies , 2006, Canadian Medical Association Journal.
[9] A. Agarwal,et al. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer. , 1999, The Journal of urology.
[10] Petra Macaskill,et al. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. , 2004, Journal of clinical epidemiology.
[11] R. Brian Haynes,et al. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. , 1994, Journal of the American Medical Informatics Association : JAMIA.
[12] K. H. Lee. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer. , 2001, Yonsei medical journal.
[13] Patrick M M Bossuyt,et al. Exploring sources of heterogeneity in systematic reviews of diagnostic tests , 2002, Statistics in medicine.
[14] Lucas M Bachmann,et al. Sample sizes of studies on diagnostic accuracy: literature survey , 2006, BMJ : British Medical Journal.
[15] T. Gasser,et al. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor. , 2000, The Journal of urology.
[16] C. Gatsonis,et al. Designing studies to ensure that estimates of test accuracy are transferable , 2002, BMJ : British Medical Journal.
[17] Marije Deutekom,et al. Tumor markers in the diagnosis of primary bladder cancer. A systematic review. , 2003, The Journal of urology.
[18] P. Bossuyt,et al. Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.
[19] J. Sterne,et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review , 2006, BMJ : British Medical Journal.
[20] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.
[21] C M Rutter,et al. A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations , 2001, Statistics in medicine.
[22] P. Glasziou,et al. Identifying studies for systematic reviews of diagnostic tests was difficult due to the poor sensitivity and precision of methodologic filters and the lack of information in the abstract. , 2005, Journal of clinical epidemiology.
[23] M. Paoluzzi,et al. Urinary dosage of nuclear matrix protein 22 (NMP22) like biologic marker of transitional cell carcinoma (TCC): a study on patients with hematuria. , 1999, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.
[24] Sarah Lord,et al. When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.
[25] P. Bossuyt,et al. Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. , 2006, Journal of clinical epidemiology.
[26] Ben Ewald,et al. Post hoc choice of cut points introduced bias to diagnostic research. , 2006, Journal of clinical epidemiology.
[27] A. K. Agarwal,et al. Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat. , 1999, The Journal of urology.
[28] P D Bezemer,et al. Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. , 2000, Journal of clinical epidemiology.
[29] B. Liu,et al. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. , 1999, Urology.
[30] Alex J Sutton,et al. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. , 2002, International journal of epidemiology.
[31] Jonathan J Deeks,et al. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. , 2005, Journal of clinical epidemiology.
[32] C. Gatsonis,et al. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. , 2006, AJR. American journal of roentgenology.
[33] C Gatsonis,et al. Meta‐analysis of Diagnostic Test Accuracy Assessment Studies with Varying Number of Thresholds , 2003, Biometrics.
[34] J R Thornbury,et al. Eugene W. Caldwell Lecture. Clinical efficacy of diagnostic imaging: love it or leave it. , 1994, AJR. American journal of roentgenology.
[35] A. Browning,et al. Evaluation of the Clinical Value of Urinary NMP22 as a Marker in the Screening and Surveillance of Transitional Cell Carcinoma of the Urinary Bladder , 2001, European Urology.
[36] P. Bossuyt,et al. Impact of adjustment for quality on results of metaanalyses of diagnostic accuracy. , 2007, Clinical chemistry.
[37] P. Bossuyt,et al. BMC Medical Research Methodology , 2002 .
[38] P. Bossuyt,et al. The quality of diagnostic accuracy studies since the STARD statement , 2006, Neurology.
[39] Haitao Chu,et al. A unification of models for meta-analysis of diagnostic accuracy studies. , 2009, Biostatistics.
[40] R. Haynes,et al. Medline : analytical survey scientifically strong studies of diagnosis from Optimal search strategies for retrieving , 2004 .
[41] C. Constantinides,et al. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. , 2001, The Journal of urology.
[42] L E Moses,et al. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. , 1993, Statistics in medicine.
[43] J. Sehouli,et al. Original Paper: A likelihood ratio approach to meta-analysis of diagnostic studies , 2003 .
[44] Ömer Öge,et al. Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer , 2004, International Urology and Nephrology.
[45] Frank Buntinx,et al. The evidence base of clinical diagnosis , 2008 .
[46] H. Biri,et al. Comparison of the Nuclear Matrix Protein 22 with Voided Urine Cytology and BTA stat Test in the Diagnosis of Transitional Cell Carcinoma of the Bladder , 1999, European Urology.
[47] Penny Whiting,et al. Bmc Medical Research Methodology Open Access No Role for Quality Scores in Systematic Reviews of Diagnostic Accuracy Studies , 2005 .
[48] K. Bichler,et al. Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer. , 2001, Urologia internationalis.
[49] Frederick Mosteller,et al. Guidelines for Meta-analyses Evaluating Diagnostic Tests , 1994, Annals of Internal Medicine.
[50] P. Bossuyt,et al. Sources of Variation and Bias in Studies of Diagnostic Accuracy , 2004, Annals of Internal Medicine.
[51] M. Leeflang,et al. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. , 2008, Clinical chemistry.
[52] K. Khan,et al. Systematic reviews of diagnostic tests: a guide to methods and application. , 2005, Best practice & research. Clinical obstetrics & gynaecology.
[53] J. Kleijnen,et al. Systematic reviews to evaluate diagnostic tests. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[54] Johannes B Reitsma,et al. Quality of reporting of diagnostic accuracy studies. , 2005, Radiology.
[55] J. C. Houwelingen,et al. Bivariate Random Effects Meta-Analysis of ROC Curves , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[56] V. Lokeshwar,et al. Urinary bladder tumor markers. , 2006, Urologic oncology.
[57] D J O'Kane,et al. Comparison of screening methods in the detection of bladder cancer. , 1999, The Journal of urology.
[58] Patrick M Bossuyt,et al. We should not pool diagnostic likelihood ratios in systematic reviews , 2008, Statistics in medicine.
[59] Penny F Whiting,et al. How does study quality affect the results of a diagnostic meta-analysis? , 2005, BMC medical research methodology.
[60] Johannes B Reitsma,et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. , 2005, Journal of clinical epidemiology.
[61] K Koiso,et al. Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria , 1999, International journal of urology : official journal of the Japanese Urological Association.
[62] Paul Glasziou,et al. Comparative accuracy: assessing new tests against existing diagnostic pathways , 2006, BMJ : British Medical Journal.
[63] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2004, Family practice.
[64] Alex J. Sutton,et al. Publication and related biases: a review , 2000 .
[65] Optimal search strategies for retrieving scientifically strong studies of diagnosis from MEDLINE: analytical survey , 2004 .